GlassScriptPhysician profile
Federico E Azpurua
NPI 1417116500
$19,614.39
in general payments reported to CMS, 2019-2025
20 companies · $2,193 in 2025
The $2,193 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,246 · 2020: $561 · 2021: $2,053 · 2022: $3,348 · 2023: $7,765 · 2024: $2,449 · 2025: $2,193.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,646 · Travel and Lodging: $3,831 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,500 · Consulting Fee: $430.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,646.33 |
| Travel and Lodging | $3,830.53 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,500.00 |
| Consulting Fee | $430.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $10,991.62 | 2019-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Medtronic, INC. | $4,054.29 | 2021-2025 | Corevalve Evolut R, Cobalt Dr Mri Surescan, Azure Xt Dr Mri Surescan |
| Abbott Laboratories | $1,003.22 | 2019-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Hi-Torque Command, Diamondback Peripheral |
| Abiomed | $943.45 | 2023-2025 | Impella |
| Shockwave Medical, INC | $560.76 | 2022-2025 | |
| Boston Scientific Corporation | $441.09 | 2019-2025 | Cds - Mct/Cem Monitoring |
| Astrazeneca Pharmaceuticals LP | $366.02 | 2019-2022 | |
| Amgen INC. | $248.70 | 2019-2025 | Repatha, Repatha |
| Pfizer INC. | $235.52 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $205.68 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $138.95 | 2021-2025 | Verquvo |
| Boehringer Ingelheim Pharmaceuticals, INC. | $135.78 | 2020-2022 | |
| Siemens Medical Solutions USA, INC. | $67.99 | 2020 | |
| Janssen Pharmaceuticals, INC | $48.93 | 2021-2023 | Xarelto |
| Cardiovascular Systems INC. | $44.91 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $44.89 | 2021-2025 | Camzyos |
| Amarin Pharma, INC. | $33.13 | 2020-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $25.36 | 2025 | |
| Tactile Systems Technology INC | $13.06 | 2019 | |
| Biotronik INC. | $11.04 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Federico Azpurua listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.